v3.26.1
Earnings Per Share
6 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
Earnings per share is computed using the treasury stock method. Stock options and stock appreciation rights to purchase 2 million and 3 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and six months ended June 30, 2026, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. For the same reason, stock options and stock appreciation rights to purchase 9 million and 10 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and six months ended June 30, 2025, respectively.

The following is a reconciliation of basic and diluted earnings per share for the three and six months ended June 30, 2026 and 2025:
Three Months Ended
June 30,
Six Months Ended
June 30,
In millions, except per share amounts2026202520262025
Numerator for earnings per share calculation:
Net income attributable to CVS Health$2,979 $1,021 $5,922 $2,800 
Denominator for earnings per share calculation:
Weighted average shares, basic1,279 1,266 1,276 1,264 
Restricted stock units and performance stock units
Stock options and stock appreciation rights
Weighted average shares, diluted1,287 1,270 1,283 1,267 
Earnings per share:
Basic$2.33 $0.81 $4.64 $2.22 
Diluted$2.31 $0.80 $4.61 $2.21